Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Sumatriptan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,014Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch
    Tonix Pharmaceuticals Announces Patent For Zembrace SymTouch

    27 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/27/2954413/28908/en/Tonix-Pharmaceuticals-Announces-Issuance-of-U-S-Patent-Covering-the-Subcutaneous-Delivery-of-FDA-Approved-Zembrace-SymTouch-to-Treat-Migraines.html

    GLOBENEWSWIRE
    27 Sep 2024
    Share Share
    Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds
    Tonix Launches Campaign On Gastroparesis Impact On Migraine Meds

    06 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/06/2942065/28908/en/Tonix-Pharmaceuticals-Launches-National-Awareness-Campaign-on-the-Impact-of-Gastroparesis-or-Stomach-Paralysis-on-the-Absorption-of-Oral-Migraine-Medications-at-PAINWeek.html

    GLOBENEWSWIRE
    06 Sep 2024
    Share Share
    Acquired approval for manufacturing and marketing generic drugs
    Acquired approval for manufacturing and marketing generic drugs

    15 Aug 2024

    // PRESS RELEASE

    https://www.towayakuhin.co.jp/english/assets/release240815.pdf

    PRESS RELEASE
    15 Aug 2024
    Share Share
    Tonix Presents Migraine Treatment Data At AHS Meeting
    Tonix Presents Migraine Treatment Data At AHS Meeting

    18 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/18/2900367/28908/en/Tonix-Pharmaceuticals-Presented-Data-Comparing-Real-World-Treatment-of-Migraine-with-Industry-Guidelines-for-Non-Oral-Products-at-the-Annual-Scientific-Meeting-of-the-American-Head.html

    GLOBENEWSWIRE
    18 Jun 2024
    Share Share
    Tonix Completes Acquisition of Two FDA-Approved, Marketed Migraine Products
    Tonix Completes Acquisition of Two FDA-Approved, Marketed Migraine Products

    03 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/03/2698433/28908/en/Tonix-Pharmaceuticals-Completes-Acquisition-of-Two-FDA-Approved-Marketed-Migraine-Products.html

    GLOBENEWSWIRE
    03 Jul 2023
    Share Share
    Caplin's Generic Sumatriptan Succinate Receives Approval in the U.S
    Caplin's Generic Sumatriptan Succinate Receives Approval in the U.S

    13 Jul 2021

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213998

    FDA
    13 Jul 2021
    Share Share